Andrea Pliakas

Massachusetts General Hospital, Boston, MA 
"Andrea Pliakas"
Mean distance: 15.16 (cluster 19)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chartoff E, Sawyer A, Rachlin A, et al. (2012) Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in rats. Neuropharmacology. 62: 167-76
Ali S, Welch CA, Park LT, et al. (2008) Encephalitis and catatonia treated with ECT. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 21: 46-51
Chartoff EH, Pliakas AM, Carlezon WA. (2006) Microinjection of the L-type calcium channel antagonist diltiazem into the ventral nucleus accumbens shell facilitates cocaine-induced conditioned place preferences. Biological Psychiatry. 59: 1236-9
Mague SD, Pliakas AM, Todtenkopf MS, et al. (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. The Journal of Pharmacology and Experimental Therapeutics. 305: 323-30
Carlezon WA, Pliakas AM, Parow AM, et al. (2002) Antidepressant-like effects of cytidine in the forced swim test in rats. Biological Psychiatry. 51: 882-9
Andersen SL, Arvanitogiannis A, Pliakas AM, et al. (2002) Altered responsiveness to cocaine in rats exposed to methylphenidate during development. Nature Neuroscience. 5: 13-4
Pliakas AM, Carlson RR, Neve RL, et al. (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 7397-403
Carlezon WA, Todtenkopf MS, McPhie DL, et al. (2001) Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 234-41
See more...